Corvus Pharmaceuticals Balance Sheet (2015-2026) | CRVS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	58.91M	72.30M	63.46M	31.46M	28.48M	24.59M	13.16M	9.65M	7.66M	20.11M	12.62M	7.46M	14.84M	4.68M	8.74M	5.00M	14.69M	2.87M	4.58M	40.10M
Short-term Investments (Quarter)															43.22M				52.17M	196.61M
Cash & Current Investments (Quarter)	58.91M	72.30M	63.46M	31.46M	28.48M	24.59M	13.16M	9.65M	7.66M	20.11M	12.62M	7.46M	14.84M	4.68M	51.96M	5.00M	14.69M	2.87M	56.75M	236.71M
Receivables - Net (Quarter)							0.59M			0.01M	0.03M	0.03M	0.04M	0.07M	0.07M	0.08M	0.09M	0.03M	0.04M	0.04M
Receivables - Other (Quarter)		0.28M	0.51M	0.37M	0.37M	0.50M	0.59M	0.43M			0.03M	0.03M	0.04M	0.07M
Receivables (Quarter)							1.18M			0.01M	0.05M	0.05M	0.07M	0.14M	0.07M	0.08M	0.09M	0.03M	0.04M	0.04M
Prepaid Assets (Quarter)	0.71M	2.15M	0.28M	0.06M	0.62M	1.15M	0.77M	0.07M	0.37M	0.21M	0.78M	0.70M	0.24M	0.63M	0.31M	0.09M	1.29M	1.22M	0.60M	0.37M
Current Assets (Quarter)	69.12M	78.76M	71.31M	64.37M	58.88M	51.27M	43.66M	35.55M	37.91M	33.09M	27.96M	22.85M	48.26M	42.92M	54.41M	45.49M	75.78M	66.94M	58.21M	239.95M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.65M	0.54M	0.45M	0.36M	0.53M	0.45M	0.35M	0.33M	0.29M	0.26M	0.24M	0.21M	0.19M	0.17M	0.15M	0.17M	0.25M	0.22M	0.22M	0.28M
Long-Term Investments (Quarter)	38.05M	36.33M	34.27M	33.37M	30.18M	25.91M	21.88M	20.23M	18.02M	17.07M	16.12M	16.07M	15.40M	15.19M	12.54M	12.06M	11.79M	11.53M	10.99M	10.50M
Long-Term Deferred Tax (Quarter)							76.95M
Other Non-Current Assets (Quarter)	0.32M	0.28M	0.24M	0.24M	0.24M	0.25M	0.13M	0.13M	0.13M	0.09M	0.09M	0.09M	0.13M	0.25M	0.63M	0.63M	0.63M	0.85M	0.85M	1.72M
Non-Current Assets (Quarter)	0.02M	0.93M	1.82M	1.80M	1.66M	1.48M	1.65M	1.57M	1.44M	1.33M	1.43M	1.27M	1.19M	1.34M	1.32M	1.21M	1.11M	1.00M	0.90M	0.80M
Assets (Quarter)	109.39M	119.32M	109.45M	101.29M	92.54M	80.35M	68.24M	58.20M	58.04M	51.94M	45.55M	40.08M	64.56M	58.81M	68.91M	59.44M	89.46M	80.47M	71.12M	253.19M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.87M	2.33M	1.56M	2.19M	2.65M	4.23M	1.98M	1.41M	2.10M	1.40M	1.52M	1.61M	1.21M	1.87M	2.58M	0.43M	3.14M	1.24M	2.49M	4.70M
Payables (Quarter)	2.87M	2.33M	1.56M	2.19M	2.65M	4.23M	1.98M	1.41M	2.10M	1.40M	1.52M	1.61M	1.21M	1.87M	2.58M	0.43M	3.14M	1.24M	2.49M	4.70M
Accumulated Expenses (Quarter)	1.63M	7.96M	1.85M	5.99M	6.37M	8.57M	7.55M	0.66M	0.80M	0.75M	0.68M	4.07M	4.30M	4.21M	0.82M	3.87M	0.82M	5.72M	6.49M	6.99M
Other Accumulated Expenses (Quarter)	0.28M	0.13M	0.12M	0.20M	0.13M	0.18M	0.16M	0.38M	0.14M	0.26M	0.24M	0.18M	0.23M	0.40M	0.29M	0.30M	0.35M	0.57M	0.24M	0.21M
Current Leases (Quarter)	1.15M	1.01M	1.05M	1.09M	1.14M	1.18M	1.23M	1.26M	1.30M	1.34M	1.37M	1.04M	0.70M	0.35M	0.18M	0.32M	0.35M	0.38M	0.40M	0.43M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	12.36M	11.30M	9.69M	9.27M	10.16M	13.98M	10.75M	8.29M	7.86M	7.30M	6.87M	6.72M	13.34M	46.41M	35.40M	9.28M	8.51M	8.07M	9.38M	12.11M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
Pension (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	0.63M	2.87M	2.60M	2.30M	2.00M	1.69M	1.37M	1.04M	0.70M	0.35M	1.37M	1.04M	0.70M	0.35M	0.94M	0.83M	0.73M	0.63M	0.53M	0.41M
Other Non-Current Liabilities (Quarter)													7.10M	39.96M	28.91M	3.78M
Total Non-Current Liabilities (Quarter)			0.10M		1.02M	0.94M	0.98M	0.90M	0.77M	0.69M	0.65M	0.59M	0.53M	0.62M	0.59M	0.50M	0.41M	0.32M	0.23M	0.14M
Total Liabilities (Quarter)	12.99M	14.18M	12.29M	11.57M	12.15M	15.67M	12.12M	9.33M	8.56M	7.65M	6.87M	6.72M	13.34M	46.41M	36.34M	10.11M	9.23M	8.71M	9.91M	12.52M
Shareholder's Equity
Common Equity (Quarter)	96.40M	105.15M	97.16M	89.72M	80.39M	64.68M	56.12M	48.87M	49.48M	44.29M	38.68M	33.36M	51.23M	12.41M	32.57M	49.33M	80.23M	71.77M	61.20M	240.68M
Shareholder's Equity (Quarter)	96.40M	105.15M	97.16M	89.72M	80.39M	64.68M	56.12M	48.87M	49.48M	44.29M	38.68M	33.36M	51.23M	12.41M	32.57M	49.33M	80.23M	71.77M	61.20M	240.68M
Liabilities and Shareholders Equity (Quarter)	109.39M	119.32M	109.45M	101.29M	92.54M	80.35M	68.24M	58.20M	58.04M	51.94M	45.55M	40.08M	64.56M	58.81M	68.91M	59.44M	89.46M	80.47M	71.12M	253.19M
Retained Earnings (Quarter)	1.40M	-257.10M	1.87M	-274.68M	-283.00M	-297.87M	-307.70M	-315.60M	-322.10M	-1.44M	-334.72M	-340.42M	-344.68M	-0.74M	-1.29M	-381.80M	-389.81M	-400.00M	-0.90M	-425.99M
Treasury Shares (Quarter)											0.40M		0.40M	0.40M

Research Tools

Developers

Corvus Pharmaceuticals Balance Sheet (2015-2026) | CRVS

Research Tools

Developers

Corvus Pharmaceuticals Balance Sheet (2015-2026) | CRVS

Create an account

Sign In

Reset Password